Income Statement Sekisui House, Ltd.

Equities

1928

JP3420600003

Homebuilding

Market Closed - Japan Exchange Other stock markets 07:30:00 15/05/2026 BST			5-day change	1st Jan Change
3,396.00 ^JPY	-0.79%		-0.32%	-2.92%

04-23	Zip Infrastructure, Inc. announced that it has received funding from Sekisui House, Ltd., Sekisui House Innovation & Communication Co., Ltd.	CI
04-21	Cierpa & Co, Inc. announced that it has received funding from a group of investors	CI

f201cc27540f485ddb3b76c0ec3350.feZrdurQJz4B6CqzImKR2zlWEf7r5XHOdVlgzuUmFMc.Ot4aQtP9XnZJiXDncwT6iA4URselhymHEGsXlolJRKYxrjMHg6AVUleSRQ

Published financial data: SEKISUI HOUSE, LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: January	2022	2023	2024	2025	2026
Revenues	2,590B	2,929B	3,107B	4,059B	4,198B
Total Revenues	2,590B	2,929B	3,107B	4,059B	4,198B
Cost of Goods Sold, Total	2,061B	2,345B	2,483B	3,273B	3,358B
Gross Profit	529B	584B	624B	786B	840B
Selling General & Admin Expenses, Total	299B	323B	353B	454B	498B
Provision for Bad Debts	98M	110M	-553M	857M	196M
Other Operating Expenses, Total	299B	323B	352B	455B	498B
Operating Income	230B	261B	272B	331B	341B
Interest Expense, Total	-3.84B	-5.32B	-12.37B	-33.63B	-39.18B
Interest And Investment Income	4.51B	4.38B	5.14B	11.45B	8.15B
Net Interest Expenses	672M	-937M	-7.23B	-22.18B	-31.03B
Income (Loss) On Equity Invest.	-1.24B	-2.09B	1.9B	-3.08B	26.1B
Currency Exchange Gains (Loss)	1.13B	-723M	4.29B	3.58B	1.29B
Other Non Operating Income (Expenses)	-636M	-472M	-1.67B	-8.05B	-9.96B
EBT, Excl. Unusual Items	230B	257B	269B	302B	328B
Gain (Loss) On Sale Of Investments	6.43B	17.09B	25.98B	23.92B	12.41B
Gain (Loss) On Sale Of Assets	-1.63B	-1.76B	-5.42B	-1.58B	-1.47B
Asset Writedown	-539M	-2.9B	-484M	-147M	-
Other Unusual Items	-20M	-1.99B	0	-18.23B	-
EBT, Incl. Unusual Items	234B	268B	289B	306B	339B
Income Tax Expense	70.32B	76.38B	81.43B	84.33B	102B
Earnings From Continuing Operations	164B	191B	208B	221B	237B
Net Income to Company	164B	191B	208B	221B	237B
Minority Interest	-10.11B	-6.81B	-5.2B	-3.55B	-4.48B
Net Income - (IS)	154B	185B	202B	218B	232B
Net Income to Common Incl Extra Items	154B	185B	202B	218B	232B
Net Income to Common Excl. Extra Items	154B	185B	202B	218B	232B
Per Share Items
Net EPS - Basic	227.37	276.58	309.29	335.95	358.07
Basic EPS - Continuing Operations	227.37	276.58	309.29	335.95	358.07
Basic Weighted Average Shares Outstanding	677M	667M	654M	648M	648M
Net EPS - Diluted	227.25	276.46	309.19	335.84	357.98
Diluted EPS - Continuing Operations	227.25	276.46	309.19	335.84	357.98
Diluted Weighted Average Shares Outstanding	677M	667M	654M	648M	648M
Normalized Basic EPS	197.52	230.81	248.95	285.42	309.16
Normalized Diluted EPS	197.41	230.71	248.87	285.34	309.08
Dividend Per Share	90	110	123	135	144
Payout Ratio	36.13	35.99	37.99	38.11	39.95
American Depositary Receipts Ratio (ADR)	1	1	1	1	1
Supplemental Items
EBITDA	254B	288B	299B	367B	384B
EBITA	230B	261B	272B	331B	341B
EBIT	230B	261B	272B	331B	341B
Effective Tax Rate - (Ratio)	30.01	28.53	28.18	27.6	30.16
Normalized Net Income	134B	154B	163B	185B	200B
Non-Cash Pension Expense	1.63B	-1.04B	-2.99B	-11.97B	-13.22B
Supplemental Operating Expense Items
Advertising Expense	55.93B	54.68B	58.86B	87.04B	89.1B
Selling and Marketing Expenses	55.93B	54.68B	58.86B	87.04B	89.1B
Research And Development Expense From Footnotes	9.48B	9.56B	9.05B	10.58B	10.52B

Fiscal Period: January	2022	2023	2024	2025	2026
Assets
Cash And Equivalents	515B	333B	293B	391B	435B
Short Term Investments	-	-	-	-	-
Total Cash And Short Term Investments	515B	333B	293B	391B	435B
Accounts Receivable, Total	131B	156B	175B	210B	203B
Total Receivables	131B	156B	175B	210B	203B
Inventory	1,204B	1,465B	1,894B	2,866B	3,060B
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	102B	140B	135B	246B	209B
Total Current Assets	1,953B	2,094B	2,497B	3,712B	3,907B
Net Property Plant And Equipment	541B	555B	496B	534B	466B
Long-term Investments	260B	284B	295B	316B	376B
Goodwill	250M	31.41B	17.81B	134B	115B
Other Intangibles, Total	17.74B	19.71B	22.58B	87.66B	101B
Loans Receivable Long-Term	5.79B	5.64B	3.97B	13.66B	23.27B
Deferred Tax Assets Long-Term	24.09B	18.22B	20.24B	10.64B	18.93B
Other Long-Term Assets, Total	2M	2M	2M	1M	1M
Total Assets	2,801B	3,008B	3,353B	4,809B	5,007B
Liabilities
Accounts Payable, Total	208B	227B	237B	274B	230B
Accrued Expenses, Total	32.66B	37.52B	39.25B	46.38B	51.64B
Short-term Borrowings	219B	306B	440B	518B	414B
Current Portion of Long-Term Debt	16.24B	102B	21.63B	253B	181B
Current Income Taxes Payable	43.02B	34.64B	39.78B	44.65B	67.87B
Unearned Revenue Current, Total	208B	192B	210B	221B	237B
Other Current Liabilities	141B	146B	150B	199B	217B
Total Current Liabilities	868B	1,045B	1,138B	1,556B	1,398B
Long-Term Debt	307B	177B	289B	1,076B	1,254B
Pension & Other Post Retirement Benefits	31.6B	29.98B	31.42B	32.49B	28.34B
Deferred Tax Liability Non Current	464M	933M	6.11B	13.44B	24.63B
Other Non Current Liabilities	73.71B	87.07B	94.08B	112B	114B
Total Liabilities	1,280B	1,340B	1,559B	2,790B	2,818B
Common Stock, Total	203B	203B	203B	203B	203B
Additional Paid In Capital	259B	260B	260B	260B	260B
Retained Earnings	940B	1,056B	1,132B	1,267B	1,407B
Treasury Stock	-20.98B	-50.66B	-40.98B	-40.96B	-40.9B
Comprehensive Income and Other	93.38B	165B	200B	273B	310B
Total Common Equity	1,474B	1,633B	1,755B	1,962B	2,140B
Minority Interest	46.83B	34.58B	39.37B	56.31B	48.62B
Total Equity	1,521B	1,668B	1,794B	2,019B	2,188B
Total Liabilities And Equity	2,801B	3,008B	3,353B	4,809B	5,007B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	675M	662M	648M	648M	648M
ECS Total Common Shares Outstanding	675M	662M	648M	648M	648M
Book Value / Share	2.18K	2.47K	2.71K	3.03K	3.3K
Tangible Book Value	1,456B	1,582B	1,714B	1,740B	1,924B
Tangible Book Value Per Share	2.16K	2.39K	2.65K	2.69K	2.97K
Total Debt	542B	585B	751B	1,847B	1,849B
Net Debt	26.73B	252B	458B	1,457B	1,414B
Debt Equivalent of Unfunded Proj. Benefit Obligation	23.53B	-3.22B	-4.72B	-15.12B	-85.34B
Minority Interest, Total (Incl. Fin. Div)	46.83B	34.58B	39.37B	56.31B	48.62B
Inventories - Raw Materials, Total	154B	182B	238B	401B	438B
Inventories - Work In Process, Total	23.58B	24.78B	24.84B	21.62B	20.74B
Inventories - Finished Goods, Total	1,027B	1,258B	1,631B	2,443B	2,601B
Full Time Employees	28.82K	29.05K	29.93K	32.26K	32.19K
Accumulated Allowance for Doubtful Accounts (Supple)	1.18B	1.14B	1.03B	1.01B	1B
Order Backlog	1,513B	1,448B	1,552B	1,755B	1,804B

Fiscal Period: January	2022	2023	2024	2025	2026
Net Income	234B	268B	289B	306B	339B
Depreciation & Amortization - CF	24.07B	26.71B	27.74B	35.24B	42.76B
Depreciation & Amortization, Total	24.07B	26.71B	27.74B	35.24B	42.76B
(Gain) Loss From Sale Of Asset	539M	2.9B	484M	147M	-
(Gain) Loss on Sale of Investments - (CF)	-3.34B	-274M	-16.2B	-20.47B	-12.41B
(Income) Loss On Equity Investments - (CF)	1.24B	2.09B	-1.9B	3.08B	-26.1B
Other Operating Activities, Total	-61.79B	-88.92B	-69.37B	-83.92B	-87.26B
Change In Accounts Receivable	13.46B	-24.16B	-19.11B	-32.74B	7.9B
Change In Inventories	-85.52B	-38.49B	-218B	-101B	-98.96B
Change In Accounts Payable	17.64B	8.28B	8.3B	-11.56B	-26.82B
Change in Other Net Operating Assets	-22.61B	-30.37B	14.78B	-31.4B	78.48B
Cash from Operations	118B	125B	15.68B	62.88B	216B
Capital Expenditure	-82.95B	-92.16B	-76.94B	-76.69B	-66.93B
Sale of Property, Plant, and Equipment	727M	2.84B	437M	798M	1.88B
Cash Acquisitions	-35.7B	-69.6B	-14.54B	-557B	-
Divestitures	87M	-	2.88B	-854M	-
Sale (Purchase) of Intangible assets	-	-	-	-	-28.16B
Investment in Marketable and Equity Securities, Total	-7.82B	-2.15B	19.5B	25.81B	648M
Net (Increase) Decrease in Loans Originated / Sold - Investing	9.48B	261M	2.59B	-74.66B	-7.88B
Other Investing Activities, Total	2.47B	-4.6B	-3.05B	-15.19B	27.27B
Cash from Investing	-114B	-165B	-69.12B	-698B	-73.17B
Short Term Debt Issued, Total	33.22B	37.36B	156B	40B	-
Long-Term Debt Issued, Total	26.75B	66.29B	85.54B	817B	347B
Total Debt Issued	59.97B	104B	241B	857B	347B
Short Term Debt Repaid, Total	-	-	-	-12.78B	-131B
Long-Term Debt Repaid, Total	-94.17B	-142B	-116B	-38.89B	-216B
Total Debt Repaid	-94.17B	-142B	-116B	-51.67B	-347B
Repurchase of Common Stock	-15.02B	-30.01B	-40.02B	-18M	-14M
Common Dividends Paid	-55.61B	-66.4B	-76.86B	-82.97B	-92.71B
Common & Preferred Stock Dividends Paid	-55.61B	-66.4B	-76.86B	-82.97B	-92.71B
Other Financing Activities, Total	-6.88B	-21.25B	-2.44B	-1.48B	-320M
Cash from Financing	-112B	-156B	6.48B	721B	-93.26B
Foreign Exchange Rate Adjustments	20.12B	13.3B	7.11B	11.24B	-5.28B
Miscellaneous Cash Flow Adjustments	2.19B	1M	-	-	-2M
Net Change in Cash	-85.06B	-182B	-39.85B	97.4B	44.62B
Supplemental Items
Cash Interest Paid	4.53B	6.81B	16.44B	32.76B	38.63B
Cash Income Tax Paid (Refund)	64.74B	94.49B	65.93B	84.02B	87.32B
Levered Free Cash Flow	-125B	-224B	-291B	-864B	3.64B
Unlevered Free Cash Flow	-123B	-221B	-283B	-843B	28.12B
Change In Net Working Capital	208B	319B	404B	1,009B	133B
Net Debt Issued / Repaid	-34.2B	-38.12B	126B	805B	-209M

Fiscal Period: January	2022	2023	2024	2025	2026
Profitability
Return on Assets	5.3	5.63	5.34	5.08	4.35
Return on Total Capital	7.22	7.57	7.08	6.46	5.4
Return On Equity %	11.35	12	11.99	11.61	11.25
Return on Common Equity	10.99	11.88	11.94	11.71	11.32
Margin Analysis
Gross Profit Margin %	20.42	19.95	20.07	19.37	20.01
SG&A Margin	11.53	11.02	11.35	11.18	11.87
EBITDA Margin %	9.82	9.84	9.63	9.03	9.15
EBITA Margin %	8.89	8.93	8.74	8.16	8.13
EBIT Margin %	8.89	8.93	8.74	8.16	8.13
Income From Continuing Operations Margin %	6.33	6.53	6.68	5.45	5.64
Net Income Margin %	5.94	6.3	6.51	5.36	5.53
Net Avail. For Common Margin %	5.94	6.3	6.51	5.36	5.53
Normalized Net Income Margin	5.16	5.26	5.24	4.56	4.77
Levered Free Cash Flow Margin	-4.84	-7.64	-9.37	-21.3	0.09
Unlevered Free Cash Flow Margin	-4.74	-7.53	-9.12	-20.78	0.67
Asset Turnover
Asset Turnover	0.95	1.01	0.98	0.99	0.86
Fixed Assets Turnover	4.81	5.35	5.91	7.88	8.39
Receivables Turnover (Average Receivables)	18.87	20.39	18.75	21.05	20.33
Inventory Turnover (Average Inventory)	1.91	1.76	1.48	1.38	1.13
Short Term Liquidity
Current Ratio	2.25	2	2.19	2.39	2.79
Quick Ratio	0.74	0.47	0.41	0.39	0.46
Operating Cash Flow to Current Liabilities	0.14	0.12	0.01	0.04	0.15
Days Sales Outstanding (Average Receivables)	19.34	17.9	19.47	17.38	17.95
Days Outstanding Inventory (Average Inventory)	190.61	207.78	246.8	266.14	322.03
Average Days Payable Outstanding	32.32	30.44	29.08	22.06	25.91
Cash Conversion Cycle (Average Days)	177.63	195.24	237.18	261.46	314.07
Long Term Solvency
Total Debt/Equity	35.64	35.05	41.85	91.5	84.49
Total Debt / Total Capital	26.27	25.96	29.5	47.78	45.8
LT Debt/Equity	20.16	10.64	16.11	53.33	57.28
Long-Term Debt / Total Capital	14.86	7.88	11.36	27.85	31.05
Total Liabilities / Total Assets	45.7	44.55	46.49	58.02	56.29
EBIT / Interest Expense	60	49.18	21.95	9.85	8.71
EBITDA / Interest Expense	66.27	54.2	24.2	10.9	9.8
(EBITDA - Capex) / Interest Expense	44.65	36.87	17.98	8.62	8.1
Total Debt / EBITDA	2.13	2.03	2.51	5.04	4.81
Net Debt / EBITDA	0.11	0.87	1.53	3.97	3.68
Total Debt / (EBITDA - Capex)	3.16	2.98	3.38	6.37	5.83
Net Debt / (EBITDA - Capex)	0.16	1.28	2.06	5.02	4.46
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	5.83	13.1	6.09	30.62	3.43
Gross Profit, 1 Yr. Growth %	11.69	10.48	6.75	26.01	6.85
EBITDA, 1 Yr. Growth %	22.08	13.36	3.86	22.47	4.79
EBITA, 1 Yr. Growth %	23.4	13.61	3.86	22.01	3.03
EBIT, 1 Yr. Growth %	23.4	13.61	3.86	22.01	3.03
Earnings From Cont. Operations, 1 Yr. Growth %	26.73	16.65	8.47	6.62	6.92
Net Income, 1 Yr. Growth %	24.58	19.89	9.65	7.6	6.61
Normalized Net Income, 1 Yr. Growth %	22.04	15.18	5.75	13.58	8.34
Diluted EPS Before Extra, 1 Yr. Growth %	25.54	21.65	11.84	8.62	6.59
Accounts Receivable, 1 Yr. Growth %	-8.3	18.81	12.47	19.76	-3.43
Inventory, 1 Yr. Growth %	27.09	21.61	29.28	51.32	6.78
Net Property, Plant and Equip., 1 Yr. Growth %	0.99	2.56	-10.51	7.65	-12.75
Total Assets, 1 Yr. Growth %	6.68	7.37	11.48	43.43	4.11
Tangible Book Value, 1 Yr. Growth %	11.38	8.63	8.37	1.52	10.57
Common Equity, 1 Yr. Growth %	11.08	10.78	7.45	11.83	9.04
Cash From Operations, 1 Yr. Growth %	-38.52	6.29	-87.5	300.98	244
Capital Expenditures, 1 Yr. Growth %	-5.19	11.1	-16.52	-0.32	-12.73
Levered Free Cash Flow, 1 Yr. Growth %	-303.42	78.76	30.06	196.93	-100.42
Unlevered Free Cash Flow, 1 Yr. Growth %	-294.06	79.55	28.51	197.61	-103.33
Dividend Per Share, 1 Yr. Growth %	13.92	22.22	11.82	9.76	6.67
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	3.55	9.41	9.54	17.72	16.23
Gross Profit, 2 Yr. CAGR %	5.18	11.08	8.6	15.98	16.04
EBITDA, 2 Yr. CAGR %	5.88	17.64	8.51	12.78	13.29
EBITA, 2 Yr. CAGR %	5.89	18.4	8.63	12.57	12.12
EBIT, 2 Yr. CAGR %	5.89	18.4	8.63	12.57	12.12
Earnings From Cont. Operations, 2 Yr. CAGR %	5.08	21.59	12.48	7.54	6.77
Net Income, 2 Yr. CAGR %	4.38	22.21	14.66	8.62	7.1
Normalized Net Income, 2 Yr. CAGR %	2.84	18.56	10.36	9.6	10.93
Diluted EPS Before Extra, 2 Yr. CAGR %	5.14	23.58	16.64	10.22	7.6
Accounts Receivable, 2 Yr. CAGR %	-0.57	4.38	15.6	16.06	7.54
Inventory, 2 Yr. CAGR %	9.46	24.32	25.39	39.87	27.12
Net Property, Plant and Equip., 2 Yr. CAGR %	2.91	1.77	-4.2	-1.85	-3.08
Total Assets, 2 Yr. CAGR %	3.11	7.02	9.4	26.45	22.2
Tangible Book Value, 2 Yr. CAGR %	8.01	10	8.5	4.89	5.95
Common Equity, 2 Yr. CAGR %	7.87	10.93	9.1	9.62	10.43
Cash From Operations, 2 Yr. CAGR %	-43.04	-19.16	-63.55	-29.2	271.4
Capital Expenditures, 2 Yr. CAGR %	11.58	2.64	-3.69	-8.78	-6.73
Levered Free Cash Flow, 2 Yr. CAGR %	-31.08	90.69	52.48	96.51	-88.83
Unlevered Free Cash Flow, 2 Yr. CAGR %	-32.14	86.66	51.9	95.57	-68.5
Dividend Per Share, 2 Yr. CAGR %	5.41	18	16.9	10.78	8.2
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	6.23	6.64	8.29	16.16	12.75
Gross Profit, 3 Yr. CAGR %	5.96	6.92	9.62	14.12	12.85
EBITDA, 3 Yr. CAGR %	6.35	8.32	12.86	12.98	10.05
EBITA, 3 Yr. CAGR %	6.75	8.41	13.34	12.92	9.3
EBIT, 3 Yr. CAGR %	6.75	8.41	13.34	12.92	9.3
Earnings From Cont. Operations, 3 Yr. CAGR %	8.16	8.81	17.04	10.49	7.33
Net Income, 3 Yr. CAGR %	6.18	9.31	17.87	12.25	7.95
Normalized Net Income, 3 Yr. CAGR %	3.39	6.8	14.13	11.43	9.18
Diluted EPS Before Extra, 3 Yr. CAGR %	6.85	10.38	19.54	13.9	9
Accounts Receivable, 3 Yr. CAGR %	47.32	5.51	7.01	16.97	9.16
Inventory, 3 Yr. CAGR %	3.06	13.37	25.95	33.5	27.83
Net Property, Plant and Equip., 3 Yr. CAGR %	0.64	2.79	-2.5	-0.4	-5.62
Total Assets, 3 Yr. CAGR %	5.1	4.51	8.49	19.74	18.52
Tangible Book Value, 3 Yr. CAGR %	7.78	8.22	9.45	6.12	6.75
Common Equity, 3 Yr. CAGR %	7.59	8.83	9.76	10	9.43
Cash From Operations, 3 Yr. CAGR %	-1.92	-29.87	-56.61	-18.93	19.91
Capital Expenditures, 3 Yr. CAGR %	15.47	11.42	-4.19	-2.58	-10.11
Levered Free Cash Flow, 3 Yr. CAGR %	30.11	-5.31	67.85	90.41	-74.68
Unlevered Free Cash Flow, 3 Yr. CAGR %	27.11	-6.14	64.82	90.07	-49.66
Dividend Per Share, 3 Yr. CAGR %	4.44	10.74	15.9	14.47	9.39
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	5.02	6.29	7.54	10.94	11.4
Gross Profit, 5 Yr. CAGR %	4.8	5.59	7.01	10.46	12.14
EBITDA, 5 Yr. CAGR %	4.17	5.79	7.21	10.08	13.03
EBITA, 5 Yr. CAGR %	4.56	5.98	7.49	10.05	12.85
EBIT, 5 Yr. CAGR %	4.56	5.98	7.49	10.05	12.85
Earnings From Cont. Operations, 5 Yr. CAGR %	5.27	6.57	9.87	8.3	12.82
Net Income, 5 Yr. CAGR %	4.78	6.73	9.49	9.04	13.44
Normalized Net Income, 5 Yr. CAGR %	3.18	4.88	6.13	7.91	12.84
Diluted EPS Before Extra, 5 Yr. CAGR %	5.34	7.47	10.66	10.32	14.61
Accounts Receivable, 5 Yr. CAGR %	22.36	28.45	33.7	9.61	7.22
Inventory, 5 Yr. CAGR %	3.84	5.99	11.47	23.31	26.42
Net Property, Plant and Equip., 5 Yr. CAGR %	-0.83	0.06	-1.32	0.91	-2.73
Total Assets, 5 Yr. CAGR %	5.1	4.45	6.8	12.79	13.78
Tangible Book Value, 5 Yr. CAGR %	5.95	6.15	8.07	6.88	8.04
Common Equity, 5 Yr. CAGR %	5.95	6.43	8.19	9.15	10.02
Cash From Operations, 5 Yr. CAGR %	0.38	-5.37	-33.99	-29.6	2.42
Capital Expenditures, 5 Yr. CAGR %	-2.59	7.94	7.39	2.86	-5.22
Levered Free Cash Flow, 5 Yr. CAGR %	108.29	78.34	38.63	26.81	-43.21
Unlevered Free Cash Flow, 5 Yr. CAGR %	92.49	85.37	36.5	25.89	-14.97
Dividend Per Share, 5 Yr. CAGR %	7.06	7.39	9.26	10.76	12.76